BIO2023: FDA CBER’s Peter Marks on COVID-19 Regulatory Impact
During a panel discussion at the BIO International Convention, Peter Marks, director of the US FDA’s Center for Biologics Evaluation and Research…
See our Cookie Privacy Policy Here